Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk patients — identifying gene-specific cancer associations they hope will inform future hereditary cancer test guidance.
Recent Posts
- Advocacy Spotlight
- Unique Roles in Genetic Counseling
- My Gene Counsel Launches Precision Medicine Pilot at Pacific Cancer Care Leveraging N-Power Medicine’s Point-of-Care Platform to Expand Access to Guideline-Based Genetic Testing
- Genetic Counselors in the C-Suite
- Oncology Insights: The Speed and Scope of Genetic Updates Expanding Genetic Testing to Advance Precision Medicine